Adial Pharmaceuticals (ADIL) Competitors $0.65 -0.05 (-7.24%) Closing price 04:00 PM EasternExtended Trading$0.66 +0.01 (+1.08%) As of 06:31 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock ADIL vs. INAB, MTEX, CLRB, SNTI, EDSA, BCAB, CMMB, BFRG, ELEV, and NXTCShould you be buying Adial Pharmaceuticals stock or one of its competitors? The main competitors of Adial Pharmaceuticals include IN8bio (INAB), Mannatech (MTEX), Cellectar Biosciences (CLRB), Senti Biosciences (SNTI), Edesa Biotech (EDSA), BioAtla (BCAB), Chemomab Therapeutics (CMMB), Bullfrog AI (BFRG), Elevation Oncology (ELEV), and NextCure (NXTC). These companies are all part of the "pharmaceutical products" industry. Adial Pharmaceuticals vs. IN8bio Mannatech Cellectar Biosciences Senti Biosciences Edesa Biotech BioAtla Chemomab Therapeutics Bullfrog AI Elevation Oncology NextCure Adial Pharmaceuticals (NASDAQ:ADIL) and IN8bio (NASDAQ:INAB) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their valuation, profitability, institutional ownership, media sentiment, earnings, risk, community ranking, dividends and analyst recommendations. Do insiders & institutionals have more ownership in ADIL or INAB? 16.4% of Adial Pharmaceuticals shares are held by institutional investors. Comparatively, 92.1% of IN8bio shares are held by institutional investors. 5.2% of Adial Pharmaceuticals shares are held by insiders. Comparatively, 15.5% of IN8bio shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth. Do analysts prefer ADIL or INAB? Adial Pharmaceuticals presently has a consensus target price of $8.00, suggesting a potential upside of 1,130.77%. IN8bio has a consensus target price of $6.00, suggesting a potential upside of 2,783.23%. Given IN8bio's higher possible upside, analysts clearly believe IN8bio is more favorable than Adial Pharmaceuticals.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Adial Pharmaceuticals 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 1 Strong Buy rating(s) 3.50IN8bio 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00 Is ADIL or INAB more profitable? Adial Pharmaceuticals' return on equity of -168.25% beat IN8bio's return on equity.Company Net Margins Return on Equity Return on Assets Adial PharmaceuticalsN/A -168.25% -148.46% IN8bio N/A -197.15%-130.48% Does the MarketBeat Community believe in ADIL or INAB? Adial Pharmaceuticals received 84 more outperform votes than IN8bio when rated by MarketBeat users. However, 74.29% of users gave IN8bio an outperform vote while only 58.51% of users gave Adial Pharmaceuticals an outperform vote. CompanyUnderperformOutperformAdial PharmaceuticalsOutperform Votes11058.51% Underperform Votes7841.49% IN8bioOutperform Votes2674.29% Underperform Votes925.71% Which has higher earnings and valuation, ADIL or INAB? IN8bio is trading at a lower price-to-earnings ratio than Adial Pharmaceuticals, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAdial PharmaceuticalsN/AN/A-$5.12M-$3.31-0.20IN8bioN/AN/A-$30.01M-$0.58-0.36 Does the media favor ADIL or INAB? In the previous week, Adial Pharmaceuticals had 1 more articles in the media than IN8bio. MarketBeat recorded 6 mentions for Adial Pharmaceuticals and 5 mentions for IN8bio. Adial Pharmaceuticals' average media sentiment score of 0.84 beat IN8bio's score of 0.75 indicating that Adial Pharmaceuticals is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Adial Pharmaceuticals 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive IN8bio 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Which has more volatility and risk, ADIL or INAB? Adial Pharmaceuticals has a beta of 1.13, meaning that its share price is 13% more volatile than the S&P 500. Comparatively, IN8bio has a beta of 0.03, meaning that its share price is 97% less volatile than the S&P 500. SummaryAdial Pharmaceuticals beats IN8bio on 9 of the 15 factors compared between the two stocks. Remove Ads Get Adial Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for ADIL and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ADIL vs. The Competition Export to ExcelMetricAdial PharmaceuticalsPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$4.27M$6.91B$5.64B$8.06BDividend YieldN/A2.73%4.56%4.02%P/E Ratio-0.207.2024.5919.03Price / SalesN/A225.82383.9393.17Price / CashN/A65.6738.1634.64Price / Book0.266.476.944.33Net Income-$5.12M$141.90M$3.20B$247.06M7 Day Performance-9.60%-3.02%-2.30%-0.53%1 Month Performance-15.58%-4.63%3.07%-3.74%1 Year Performance-53.57%-8.61%11.15%1.72% Adial Pharmaceuticals Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ADILAdial Pharmaceuticals2.8835 of 5 stars$0.65-7.2%$8.00+1,130.8%-48.7%$4.27MN/A-0.2020Short Interest ↓Gap DownINABIN8bio3.3959 of 5 stars$0.23-2.1%$6.00+2,532.7%-83.3%$18.52MN/A-0.3020Short Interest ↑MTEXMannatech0.5439 of 5 stars$9.62-0.8%N/A+8.0%$18.13M$121.55M-11.88250Earnings ReportAnalyst ForecastNews CoverageGap UpCLRBCellectar Biosciences2.1721 of 5 stars$0.39+5.7%$17.67+4,427.6%-90.6%$17.98MN/A-0.2310Analyst ForecastShort Interest ↑Gap UpSNTISenti Biosciences3.6766 of 5 stars$3.72+1.1%$10.00+168.8%-13.8%$17.97M$2.56M-0.244Earnings ReportShort Interest ↓EDSAEdesa Biotech3.6412 of 5 stars$2.56+2.4%$21.00+720.3%-38.3%$17.90MN/A-1.3720Positive NewsBCABBioAtla2.4831 of 5 stars$0.37+5.4%$6.00+1,521.6%-87.6%$17.89M$11M-0.2260Short Interest ↑News CoverageCMMBChemomab Therapeutics3.5484 of 5 stars$1.24-3.1%$9.00+625.8%+54.9%$17.81MN/A-1.2420Short Interest ↓News CoverageGap UpBFRGBullfrog AI1.4019 of 5 stars$1.89+7.4%N/A-45.6%$17.79M$60,000.00-2.224Short Interest ↓ELEVElevation Oncology2.4511 of 5 stars$0.29-3.4%$3.39+1,067.5%-94.7%$17.17MN/A-0.3540Analyst ForecastAnalyst RevisionNXTCNextCure4.5685 of 5 stars$0.61+6.8%$3.50+474.7%-73.0%$17.06MN/A-0.2990Positive NewsGap Down Remove Ads Related Companies and Tools Related Companies IN8bio Alternatives Mannatech Alternatives Cellectar Biosciences Alternatives Senti Biosciences Alternatives Edesa Biotech Alternatives BioAtla Alternatives Chemomab Therapeutics Alternatives Bullfrog AI Alternatives Elevation Oncology Alternatives NextCure Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:ADIL) was last updated on 3/27/2025 by MarketBeat.com Staff From Our PartnersA market crash is coming—here’s whenThe stock market cycle I've used to identify the most likely day of the next market crash is the exact same in...Chaikin Analytics | SponsoredYour Wealth is Under AttackPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | SponsoredA brutally honest economic warning for 2025 (see proof)New York Times best-selling financial author and world-renowned economist Addison Wiggin (a man who’s worked s...Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredEx CIA predicts 40% “double crash” – April 11The scientists here don’t study deadly viruses… directed energy weapons… or even weather control technology… ...Paradigm Press | Sponsored“Amazon Coin” set to outperform BitcoinChris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Adial Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Adial Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy ADIL Stock Free ADIL Stock Alerts